Brian Seifried
About Brian Seifried
Brian Seifried is a Research Investigator at Bristol-Myers Squibb, specializing in combining biological and chemical synthesis to develop novel materials.
Current Role at Bristol-Myers Squibb
Brian Seifried is currently a Research Investigator at Bristol-Myers Squibb in New Brunswick, New Jersey. He began his tenure at the company in July 2019. In this role, Brian is involved in combining biological and chemical synthesis to develop materials with novel and tunable properties. His work is guided by his motivation to address challenges and opportunities in material development within chemical organizations.
Education and Academic Background
Brian Seifried holds a Doctor of Philosophy (PhD) in Chemical Engineering from the Massachusetts Institute of Technology (MIT), where he studied from 2013 to 2019. Prior to that, he was part of the Denning Technology & Management Program and earned a Minor in Engineering & Business from 2010 to 2012. Brian completed his undergraduate studies at the Georgia Institute of Technology, where he studied from 2009 to 2013.
Previous Academic Positions
Before joining Bristol-Myers Squibb, Brian Seifried held various research positions. He was a Research Assistant at the Massachusetts Institute of Technology (MIT) from 2013 to 2019 in Cambridge, MA. Additionally, he served as an Undergraduate Researcher twice at the Georgia Institute of Technology, first from 2009 to 2012 and again from 2012 to 2013, in Atlanta, GA.
Industry Experience at Merck
Brian Seifried gained valuable industry experience through internships at Merck. In 2012, he was a Summer Intern in the Chemical Process Development and Commercialization Department in Rahway, NJ. He also interned in the Bio/Sterile Validation Department at Merck in the summer of 2011, located in West Point, PA.
Professional Background
Brian Seifried's professional background showcases a combination of academic research and industry experience. His work focuses on the development of materials with novel and tunable properties, leveraging his expertise in both biological and chemical synthesis. He has contributed to research initiatives at prestigious institutions like MIT and the Georgia Institute of Technology and has gained experience with chemical processes during his internships at Merck.